| scholarly article | Q13442814 |
| P50 | author | Stefan R. Bornstein | Q17126504 |
| Jacques W M Lenders | Q96035399 | ||
| Lorenz C Hofbauer | Q56635718 | ||
| Graeme Eisenhofer | Q64821279 | ||
| P2093 | author name string | Roland Därr | |
| Bernd Naumann | |||
| P2860 | cites work | Germline mutations in TMEM127 confer susceptibility to pheochromocytoma | Q24299202 |
| Phaeochromocytoma--recent progress in its management | Q28142726 | ||
| Biochemical diagnosis of pheochromocytoma: which test is best? | Q28208107 | ||
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma | Q28241168 | ||
| High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing | Q28258042 | ||
| Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations | Q28278673 | ||
| Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma | Q28366764 | ||
| Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy | Q28477147 | ||
| Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma | Q29614552 | ||
| Repeat adrenocortical-sparing adrenalectomy for recurrent hereditary pheochromocytoma | Q30320521 | ||
| Tumor recurrence and hypertension persistence after successful pheochromocytoma operation | Q73336326 | ||
| Pheochromocytoma; a study of 15 cases diagnosed at autopsy | Q73667542 | ||
| Phaeochromocytoma in pregnancy | Q73741015 | ||
| Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma | Q73855681 | ||
| Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas | Q74812615 | ||
| Twenty-six-years' survival with multiple bone metastasis of malignant pheochromocytoma | Q77425935 | ||
| Laparoscopic removal of a right adrenal pheochromocytoma in a pregnant woman | Q77574546 | ||
| Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases | Q78015705 | ||
| Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma | Q78114983 | ||
| [Recklinghausen's neurofibromatosis and pheochromocytoma.] | Q79325882 | ||
| Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas | Q79476042 | ||
| Surgical management of hereditary pheochromocytoma | Q79839309 | ||
| Phaeochromocytoma in pregnancy | Q80119315 | ||
| The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling | Q80318764 | ||
| Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma | Q80406302 | ||
| Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Septe | Q80741669 | ||
| An assessment of biochemical tests for the diagnosis of pheochromocytoma | Q80761719 | ||
| High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet? | Q80825422 | ||
| Single-access retroperitoneoscopic adrenalectomy (SARA) versus conventional retroperitoneoscopic adrenalectomy (CORA): a case-control study | Q83157111 | ||
| Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal | Q85058615 | ||
| Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma | Q46252973 | ||
| Pheochromocytoma in pregnancy: a review of the Japanese literature | Q46364142 | ||
| Phaeochromocytoma and pregnancy--an updated appraisal | Q46383161 | ||
| 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. | Q46660398 | ||
| Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. | Q46725902 | ||
| Genetic testing in pheochromocytoma or functional paraganglioma | Q46825172 | ||
| Mutations in SDHC cause autosomal dominant paraganglioma, type 3. | Q47817141 | ||
| Effects of Mg2+ and Ca2+ on noradrenaline release and uptake in adrenergic nerve granules in differential media | Q47931170 | ||
| Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma | Q48840738 | ||
| Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. | Q51374522 | ||
| Safe and cost-effective preoperative preparation of patients with pheochromocytoma. | Q51390154 | ||
| Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine. | Q51510849 | ||
| Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. | Q51625010 | ||
| Use of desflurane during resection of phaeochromocytoma. | Q51632789 | ||
| Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. | Q51745490 | ||
| Hypoglycemia following bilateral adrenalectomy for pheochromocytoma | Q51772590 | ||
| Use of diltiazem to control circulatory fluctuations during resection of a phaeochromocytoma. | Q51773287 | ||
| Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy | Q51774409 | ||
| Phaeochromocytoma removal and postoperative hypoglycaemia. | Q51819793 | ||
| Use of labetalol during anesthesia for pheochromocytoma removal. | Q51850209 | ||
| Effect of thiopental induction on sympathetic activity. | Q51852924 | ||
| ORG NC45 (Norcuron) and pheochromocytoma: a report of three cases. | Q51864764 | ||
| Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? | Q51928842 | ||
| Enflurane Anesthesia for Surgical Removal of Pheochromocytoma | Q52710651 | ||
| Is there still a place for adrenal venous sampling in the diagnostic localization of pheochromocytoma? | Q53229780 | ||
| Management and treatment of pheochromocytomas and paragangliomas. | Q53246827 | ||
| Laparoscopic adrenalectomy: a new standard of care. | Q53970297 | ||
| Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. | Q55033220 | ||
| Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. | Q55034471 | ||
| Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma | Q57817523 | ||
| SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas | Q62996335 | ||
| Phaeochromocytoma | Q66703497 | ||
| Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man | Q67293470 | ||
| Postoperative management of patients with pheochromocytoma | Q67356955 | ||
| Reversible myocardial depression after massive catecholamine release from a pheochromocytoma | Q68090676 | ||
| Perioperative management of 63 patients with pheochromocytoma | Q68362217 | ||
| Treatment of pheochromocytoma with dilevalol | Q68782079 | ||
| Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases | Q69862489 | ||
| Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase | Q70061421 | ||
| Oncologic aspects of pheochromocytoma: the importance of follow-up | Q70689865 | ||
| Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma | Q71092019 | ||
| Laparoscopic approach to pheochromocytoma: hemodynamic changes and catecholamine secretion | Q71184069 | ||
| Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma | Q71234775 | ||
| Pheochromocytoma | Q71739841 | ||
| Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes | Q72221317 | ||
| Cardiac Arrhythmias Associated with Succinylcholine in a Patient with Pheochromocytoma | Q72231597 | ||
| Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI | Q72947996 | ||
| Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison | Q73110130 | ||
| Cardiological effects of catecholamine-secreting tumours | Q73193736 | ||
| Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases | Q30893777 | ||
| High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma | Q33349096 | ||
| Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma | Q33430861 | ||
| Pheochromocytoma associated with pregnancy: case report and review of the literature | Q33764794 | ||
| Nuclear medicine imaging of pheochromocytoma and neuroblastoma | Q33776952 | ||
| A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. | Q33891345 | ||
| SDHA is a tumor suppressor gene causing paraganglioma | Q33980332 | ||
| Pheochromocytoma: inherited associations, bilaterality, and cortex preservation | Q34103572 | ||
| Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma | Q34142563 | ||
| Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland | Q34151602 | ||
| SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma | Q34158478 | ||
| Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center | Q34215700 | ||
| Laparoscopic adrenalectomy for pheochromocytoma | Q34281946 | ||
| The case for laparoscopic adrenalectomy | Q34310494 | ||
| Successful outcomes in pheochromocytoma surgery in the modern era. | Q34502338 | ||
| Pheochromocytomas: can malignant potential be predicted? | Q34502999 | ||
| Germ-line mutations in nonsyndromic pheochromocytoma | Q34523021 | ||
| Malignant pheochromocytoma: current status and initiatives for future progress | Q34550903 | ||
| Preoperative pharmacological management of phaeochromocytoma. | Q34571129 | ||
| Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location | Q34622491 | ||
| Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine | Q34687992 | ||
| Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma | Q34688331 | ||
| Perioperative management of pheochromocytoma | Q34694693 | ||
| Preoperative management of the pheochromocytoma patient | Q34711597 | ||
| Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease | Q34726998 | ||
| Diagnosis and management of pheochromocytoma during pregnancy | Q34730035 | ||
| Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma | Q35190348 | ||
| Pheochromocytoma: state-of-the-art and future prospects | Q35200350 | ||
| Pheochromocytoma: the expanding genetic differential diagnosis | Q35203185 | ||
| Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma | Q35649629 | ||
| The clinically inapparent adrenal mass: update in diagnosis and management | Q35745002 | ||
| Functional imaging of endocrine tumors: role of positron emission tomography | Q35856222 | ||
| Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status | Q36024376 | ||
| Phaeochromocytoma | Q36236107 | ||
| An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis | Q36477902 | ||
| An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges | Q36652761 | ||
| Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. | Q36712963 | ||
| 10 Endocrine emergencies in pregnancy | Q36773901 | ||
| Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma | Q36898854 | ||
| Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene | Q37061292 | ||
| Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population | Q37093122 | ||
| Pheochromocytoma and extra-adrenal paraganglioma: updates | Q37236356 | ||
| The protean manifestations of pheochromocytoma | Q37401210 | ||
| Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma | Q37482780 | ||
| Surgical management of pheochromocytoma with the use of metyrosine | Q37604648 | ||
| Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? | Q37885596 | ||
| Cardiovascular manifestations of phaeochromocytoma. | Q37913950 | ||
| Phaeochromocytoma in pregnancy. Five cases and a review of the literature | Q38671536 | ||
| Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics | Q38926196 | ||
| Mydriasis and acute pulmonary oedema complicating laparoscopic removal of phaechromocytoma | Q39224997 | ||
| Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker | Q39465845 | ||
| Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management | Q39750975 | ||
| Non-obstetric surgery during pregnancy | Q39987012 | ||
| Anaesthetic management of patients with phaeochromocytoma | Q40179424 | ||
| Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma | Q40562855 | ||
| Surgical excision of malignant pheochromocytoma in the left atrium | Q40623176 | ||
| Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. | Q40663240 | ||
| Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma | Q40697568 | ||
| Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma | Q41259246 | ||
| The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors | Q41323863 | ||
| Pheochromocytoma: issues in diagnosis & treatment | Q41508771 | ||
| Cardiovascular manifestations of pheochromocytoma | Q42047444 | ||
| Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma | Q42268937 | ||
| The preoperative management of phaeochromocytoma | Q42543021 | ||
| Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma | Q42620411 | ||
| Pilot quality assurance programme for plasma metanephrines | Q43166881 | ||
| The pressor effect of droperidol on a patient with pheochromocytoma | Q43676391 | ||
| 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma | Q43681931 | ||
| Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats | Q43872407 | ||
| Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas | Q44015445 | ||
| Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma | Q44112059 | ||
| Alpha blockade in preoperative preparation of patients with pheochromocytomas | Q44196298 | ||
| Hypertensive response to labetalol in phaeochromocytoma | Q44198676 | ||
| The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. | Q44393465 | ||
| Diabetes as a marker of pheochromocytoma in hypertensive patients | Q44552296 | ||
| Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. | Q44590672 | ||
| Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? | Q44688529 | ||
| Pheochromocytomas: detection with 11C hydroxyephedrine PET. | Q44748940 | ||
| Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. | Q44758334 | ||
| The diagnosis of pheochromocytoma. Overnight excretion of catecholamine metabolites | Q44839410 | ||
| Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma | Q45219918 | ||
| P433 | issue | 1 | |
| P921 | main subject | phaeochromocytoma | Q536269 |
| P304 | page(s) | 11-26 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Therapeutic advances in endocrinology and metabolism | Q26853790 |
| P1476 | title | Pheochromocytoma - update on disease management | |
| P478 | volume | 3 |
| Q91691791 | A Case of Sudden Death: Subarachnoid Hemorrhage, Pheochromocytoma, Berry Aneurysm |
| Q45916403 | A Giant Adrenal Mass in a Super Obese Patient. |
| Q89429331 | Absence of BRAF mutation in pheochromocytoma and paraganglioma |
| Q39239753 | Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review. |
| Q64230378 | An analysis of surveillance screening for SDHB-related disease in childhood and adolescence |
| Q43988472 | Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions |
| Q38543355 | Carotid baroreflex activation therapy for resistant hypertension |
| Q50667667 | Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma. |
| Q58805905 | Diagnostic and surgical challenges of a giant pheochromocytoma in a resource limited setting-A case report |
| Q47654066 | Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report |
| Q37597995 | Functional paraganglioma |
| Q37505830 | Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours |
| Q33690484 | Largest pheochromocytoma reported in Canada: A case study and literature review |
| Q53016431 | Lung metastasis and pheochromocytomas: Detection using FDG PET/CT. |
| Q33577889 | Noncoding RNAs in endocrine malignancy |
| Q38966408 | Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers |
| Q34491095 | Pelvic pheochromocytoma: a rare lethal tumor initially presenting as tuboovarian mass to gynaecologist |
| Q38150367 | Phaeochromocytoma [corrected] crisis. |
| Q55078471 | Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers. |
| Q41061561 | Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study. |
| Q97422590 | Robotic-Assisted Partial Nephrectomy and Adrenalectomy: Case of a Pheochromocytoma Invading into Renal Parenchyma |
| Q87567368 | The evaluation and treatment of endocrine forms of hypertension |
| Q47921456 | When should genetic testing be performed in patients with neuroendocrine tumours? |
Search more.